:----------: :---------------------------:
: FORM 4 : : OMB APPROVAL :
:----------: :---------------------------:
:OMB NUMBER 3235-0287 :
:EXPIRES:SEPTEMBER 30, 1998 :
:ESTIMATED AVERAGE BURDEN :
:HOURS PER RESPONSE.... 0.5 :
:---------------------------:
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
|_| CHECK THIS BOX IF NO LONGER SUBJECT TO SECTION 16. FORM 4
OR FORM 5 OBLIGATIONS MAY CONTINUE. SEE INSTRUCTION 1(B).
================================================================================
1. Name and Address of Reporting Person
Van Sue
-----------------------------------------------------------------------------
(Last) (First) (Middle)
c/o Coulter Pharmaceutical, Inc.
550 California Avenue, Suite 200
-----------------------------------------------------------------------------
(Street)
Palo Alto CA 94306
-----------------------------------------------------------------------------
(City) (State) (Zip)
================================================================================
2. Issuer Name and Ticker or Trading Symbol
Coulter Pharmaceutical, Inc. ("CLTR")
-----------------------------------------------------------------------------
================================================================================
3. IRS or Social Security Number of Reporting Person (Voluntary)
-----------------------------------------------------------------------------
================================================================================
4. Statement for Month/Year
October/1997
-----------------------------------------------------------------------------
================================================================================
5. If Amendment, Date of Original (Month/Year)
-----------------------------------------------------------------------------
================================================================================
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (Specify below)
-----------------------------------------------------------------------------
================================================================================
7. Individual or Joint/Group Filing (Check Applicable Line)
__X__ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
================================================================================
<PAGE>
TABLE I-NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
<TABLE>
<CAPTION>
1.Title of Security 2.Trans- 3.Trans- 4.Securities Acquired (A) 5.Amount of 6.Ownership 7.Nature of
(Instr. 3) action action or Disposed of (D) Securities Bene- Form: Direct Indirect
Date Code (Instr. 3, 4 and 5) ficially Owned (D) or Beneficial
(Month/ (Instr. 8) ------------------------ at End of Indirect (I) Ownership
Day/ ------------ Amount (A) or Price Month (Instr. (Instr. 4) (Instr. 4)
Year) Code V (D) 3 and 4)
- ------------------- --------- ------------ ------------------------ ------------------ -------------- ---------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Common Stock 10/31/97 J(1) 951,334 A 951,334 I (1)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 10/31/97 J(2) 389,166 A 389,166 I (2)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 34,584 D
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over)
* If the form is filed by more than one reporting person, see
Instruction 4(b)(v).
<FN>
(1) These securities are held by the Coulter Family Limited Partnership. Ms.
Van is trustee of the Wallace H. Coulter Trust, which is a co-general
partner of the Coulter Family Limited Partnership. The Coulter Family
Limited Partnership acquired these securities as a dividend paid upon the
shares of Coulter Corporation's stock in connection with the sale of the
stock of Coulter Corporation to Beckman Instruments, Inc.
(2) These securities are held by the Wallace H. Coulter Charitable Remainder
Unitrust. Ms. Van is trustee of the Wallace H. Coulter Charitable Remainder
Unitrust, which acquired these securities as a dividend paid upon the
shares of Coulter Corporation's stock in connection with the sale of the
stock of Coulter Corporation to Beckman Instruments, Inc.
(3) The option vests in four annual installments beginning on July 30, 1998.
</FN>
</TABLE>
SEC 1474 (7/96)
<PAGE>
FORM 4 (CONTINUED)
TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
(E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
1. Title of Derivative Security (Instr. 3)
Option (right to buy)
---------------------------------------------------------------------------
================================================================================
2. Conversion or Exercise Price of Derivative Security
$8.625
---------------------------------------------------------------------------
================================================================================
3. Transaction Date (Month/Day/Year)
7/30/97
---------------------------------------------------------------------------
================================================================================
4. Transaction Code (Instr. 8)
Code V
------------------ ------------
A
================================================================================
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
(A) (D)
------------------ ------------
10,000
================================================================================
6. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable Expiration Date
------------------------ ------------------------
(3) 7/30/07
================================================================================
7. Title and Amount of Underlying Securities (Instr. 3 and 4)
Title Amount or Number of Shares
------------------ --------------------------
Common Stock 10,000
================================================================================
8. Price of Derivative Security (Instr. 5)
================================================================================
9. Number of Derivative Securities Beneficially Owned at End of Month
(Instr. 4)
---------------------------------------------------------------------------
================================================================================
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
D
---------------------------------------------------------------------------
================================================================================
11. Nature of Indirect Beneficial Ownership (Instr. 4)
---------------------------------------------------------------------------
================================================================================
Explanation of Responses:
/s/ Sue Van 12/8/97
--------------------------------------- ---------------
**Signature of Reporting Person Date
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
Page 2
SEC 1474 (7/96)
Potential persons who are to respond to
the collection of information contained
in this form are not required to respond
unless the form displays a currently
valid OMB Number.
